| Extending thrombolysis to 4· 5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data BCV Campbell, H Ma, PA Ringleb, MW Parsons, L Churilov, M Bendszus, ... The Lancet 394 (10193), 139-147, 2019 | 450 | 2019 |
| Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial JR Sims, JA Zimmer, CD Evans, M Lu, P Ardayfio, JD Sparks, AM Wessels, ... Jama 330 (6), 512-527, 2023 | 378 | 2023 |
| Dementia, stroke, and vascular risk factors; a review R Sahathevan, A Brodtmann, GA Donnan International Journal of Stroke 7 (1), 61-73, 2012 | 304 | 2012 |
| Fibre-specific white matter reductions in Alzheimer’s disease and mild cognitive impairment R Mito, D Raffelt, T Dhollander, DN Vaughan, JD Tournier, O Salvado, ... Brain 141 (3), 888-902, 2018 | 263 | 2018 |
| Post-stroke cognitive impairment and dementia NS Rost, A Brodtmann, MP Pase, SJ van Veluw, A Biffi, M Duering, ... Circulation research 130 (8), 1252-1271, 2022 | 256 | 2022 |
| Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study KM Moore, J Nicholas, M Grossman, CT McMillan, DJ Irwin, L Massimo, ... The Lancet Neurology 19 (2), 145-156, 2020 | 236 | 2020 |
| Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: the EXTEND-IA TNK part 2 randomized … BCV Campbell, PJ Mitchell, L Churilov, N Yassi, TJ Kleinig, RJ Dowling, ... Jama 323 (13), 1257-1265, 2020 | 199 | 2020 |
| Fluctuating cognition in dementia with Lewy bodies and Alzheimer’s disease is qualitatively distinct J Bradshaw, M Saling, M Hopwood, V Anderson, A Brodtmann Journal of Neurology, Neurosurgery & Psychiatry 75 (3), 382-387, 2004 | 198 | 2004 |
| The importance of cognition to quality of life after stroke TB Cumming, A Brodtmann, D Darby, J Bernhardt Journal of psychosomatic research 77 (5), 374-379, 2014 | 191 | 2014 |
| A human depression circuit derived from focal brain lesions JL Padmanabhan, D Cooke, J Joutsa, SH Siddiqi, M Ferguson, RR Darby, ... Biological psychiatry 86 (10), 749-758, 2019 | 178 | 2019 |
| Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data G Thomalla, F Boutitie, H Ma, M Koga, P Ringleb, LH Schwamm, O Wu, ... The Lancet 396 (10262), 1574-1584, 2020 | 137 | 2020 |
| Neuroimaging standards for research into small vessel disease—advances since 2013 M Duering, GJ Biessels, A Brodtmann, C Chen, C Cordonnier, ... The Lancet Neurology 22 (7), 602-618, 2023 | 132 | 2023 |
| Brain stimulation and brain lesions converge on common causal circuits in neuropsychiatric disease SH Siddiqi, FL Schaper, A Horn, J Hsu, JL Padmanabhan, A Brodtmann, ... Nature human behaviour 5 (12), 1707-1716, 2021 | 132 | 2021 |
| The right supramarginal gyrus is important for proprioception in healthy and stroke-affected participants: a functional MRI study E Ben-Shabat, TA Matyas, GS Pell, A Brodtmann, LM Carey Frontiers in neurology 6, 166907, 2015 | 125 | 2015 |
| Action myoclonus–renal failure syndrome: characterization of a unique cerebro-renal disorder AP Badhwar, SF Berkovic, JP Dowling, M Gonzales, S Narayanan, ... Brain 127 (10), 2173-2182, 2004 | 116 | 2004 |
| Cortical excitability and neurology: insights into the pathophysiology RAB Badawy, T Loetscher, RAL Macdonell, A Brodtmann Functional neurology 27 (3), 131, 2012 | 106 | 2012 |
| The impact of physical activity before and after stroke on stroke risk and recovery: a narrative review SF Kramer, SH Hung, A Brodtmann Current neurology and neuroscience reports 19, 1-9, 2019 | 89 | 2019 |
| Beyond BOLD: optimizing functional imaging in stroke populations M Veldsman, T Cumming, A Brodtmann Human brain mapping 36 (4), 1620-1636, 2015 | 88 | 2015 |
| Supranutritional sodium selenate supplementation delivers selenium to the central nervous system: results from a randomized controlled pilot trial in Alzheimer’s disease BR Cardoso, BR Roberts, CB Malpas, L Vivash, S Genc, MM Saling, ... Neurotherapeutics 16, 192-202, 2019 | 87 | 2019 |
| A phase IIa randomized control trial of VEL015 (Sodium Selenate) in mild-moderate Alzheimer’s disease CB Malpas, L Vivash, S Genc, MM Saling, P Desmond, C Steward, ... Journal of Alzheimer's Disease 54 (1), 223-232, 2016 | 83 | 2016 |
